🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

The large volume of gravely ill & dead kids directly attributable to Facebook’s willful amplification of anti-vax propaganda dwarfs a) any faux benefit FB likes to claim (“oooh! 3 bone marrow matches!”) & b) any impact Zuck’s performative tax-deductible charity will ever have

Masks work. Climate change is real. Vaccines are effective. Trust scientists.

First interim data reported for LY-CoV555, the first #COVID-19 antibody arising from our AbCellera / Former Account of Eli Lilly and Company collaboration #COVID19 #antibody

Honored to make it to the list, and be recognized among such peers. #innovation #antibodies #innovationculture

LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection biorxiv.org/cgi/content/sh… #bioRxiv

Congratulations to Former Account of Eli Lilly and Company for submitting its EUA to the U.S. FDA for LY-CoV555, an AbCellera-discovered COVID-19 antibody

The U.S. FDA  has granted emergency use authorization for one of Lilly's neutralizing antibodies to treat mild to moderate #COVID19 in high-risk patients. Learn more: e.lilly/35conmQ

Absolutely delighted to see the antibody developed by Eli Lilly and Company and AbCellera receiving emergency use authorization to fight the covid outbreak. What an outstanding effort led by the pharma and biotech community to develop at record pace eff…lnkd.in/gZ9B7MC

Another major success for Defense Advanced Research Projects Agency (DARPA), demonstrating the value of funding high-risk/high-reward technologies related to biologics to anticipate future challenges. Especially relevant today with #COVID, having invest…lnkd.in/gigdt2r

1/n As we watch NEW strains of COVID emerge, it becomes even more important to get vaccinated. New strains can only emerge as the virus multiplies within hosts. More hosts = more strains. It is a number's game.

Eli Lilly and Company neutralizing antibody bamlanivimab (LY-CoV555), an AbCellera discovered molecule, prevented COVID-19 at nursing homes in the BLAZE-2 Phase 3 trial, reducing risk by up to 80 percent for residents. lnkd.in/gF9ukwx

New AbCellera-Discovered Antibody that Neutralizes Viral Variants of COVID-19, LY-CoV1404, Enters Clinical Trials Preprint data shows LY-CoV1404 binds and neutralizes all currently known circulating SARS-CoV-2 variants of concern: ow.ly/fMBx50EEbh8

Eli Lilly CEO on CNBC's Closing Bell now. Says third #covid19 antibody drug, 1404, has data showing it neutralizes both delta and omicron. In process of talking with regulators in places like Germany and US to see how it can be made available under EUA.

Former Account of Eli Lilly and Company announces that our second antibody for COVID-19, bebtelovimab (1404), neutralizes #Omicron and #Delta variants. ow.ly/HCsK50HcrpH

The partnership between @AbCellera and Former Account of Eli Lilly and Company continues to churn out society-saving level medicines- most recently with the announcement that 1404 #antibody neutralizes both the #Delta and #Omicron Variants

After close to 10 incredible years, today is my last day at AbCellera Being part of the founding/leadership team was a privilege; deepest gratitude to colleagues for the accomplishments. Excited to explore the next steps at the interface of science, business & innovation

This is just startling: Footage from another world, the planet Mars, taken by NASA's Curiosity rover.

Happy and honoured to be advising on business strategy 5 Prime Sciences. Leveraging human genetics for drug development is an imperative, terrific business traction and team led by brent richards

A terrific read about the pioneering work done on Transformer, including Inceptive’s very own CEO ⁦Jakob Uszkoreit⁩, and its impact on the explosion on AI applications. This is what Inceptive has pushed further to design the next generation mRNA therapeutics ft.com/content/37bb01…

Terrific partnership announced between Eli Lilly and Company and 5 Prime Sciences. Congrats brent richards and team for the progress on developing advanced -omics capabilities for target validation, an often under-appreciated gap in drug discovery and development